Gian Life Care Stock Screener | Share Price & Fundamental Analysis
GIANLIFE
Healthcare Service Provider
Screen Gian Life Care share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹8.87
▼
-0.08 (-0.89%)
Market Cap
₹9.09 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.45
EPS (TTM)
₹-0.04
Dividend Yield
-
Debt to Equity
0.28
52W High
₹19.92
52W Low
₹7.39
Operating Margin
16.00%
Profit Margin
-
Revenue (TTM)
₹1.00
EBITDA
-
Net Income
-
Total Assets
₹36.00
Total Equity
₹19.00
Gian Life Care Share Price History - Stock Screener Chart
Screen GIANLIFE historical share price movements with interactive charts. Analyze price trends and patterns.
Gian Life Care Company Profile - Fundamental Screener
Screen Gian Life Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GIANLIFE shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE063601012
Gian Life Care Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen GIANLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 36 | 33 | 28 | 23 |
| Current Assets | 18 | 13 | 12 | 10 |
| Fixed Assets | 4 | 5 | 5 | 4 |
| Liabilities | ||||
| Total Liabilities | 36 | 33 | 28 | 23 |
| Current Liabilities | 4 | 3 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 19 | 19 | 15 | 14 |
| Share Capital | 10 | 10 | 10 | 10 |
| Reserves & Surplus | 9 | 9 | 5 | 4 |
Screen GIANLIFE income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar | 2021-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 2 | 2 | 2 | 5 | 4 | 2 | 3 | 2 | 5 | 3 | 3 | 3 | 6 |
| Expenses | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 4 | 2 |
| EBITDA | 0 | 0 | 1 | 0 | 0 | 3 | 2 | 1 | 1 | -1 | 2 | 1 | 0 | -1 | 4 |
| Operating Profit % | 16.00% | -1.00% | 30.00% | 11.00% | 11.00% | 66.00% | 58.00% | 14.00% | 21.00% | -49.00% | 45.00% | 15.00% | -4.00% | -62.00% | 65.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -1 | 0 | 0 | 0 | 3 | 2 | 0 | 0 | -1 | 2 | 1 | 0 | -2 | 4 |
| Tax | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Net Profit | 0 | -1 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | -1 | 2 | 1 | 0 | -1 | 3 |
| EPS | 0.05 | -0.59 | 0.34 | 0.12 | 0.09 | 2.07 | 1.50 | 0.20 | 0.25 | -0.92 | 1.80 | 0.44 | 0.00 | -1.13 | 6.21 |
Gian Life Care Cash Flow Screener - Liquidity Fundamentals
Screen GIANLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 0 | 1 | 2 | 6 |
| Investing Activities | 0 | 0 | -1 | -4 |
| Financing Activities | 0 | 0 | 0 | 1 |
| Net Cash Flow | 1 | 0 | 1 | 2 |
Screen GIANLIFE shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 32.09% | 32.09% | 32.09% | 48.47% | 32.82% | 31.99% | 32.09% | 56.90% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% |
| Public Holding | 57.72% | 57.96% | 54.15% | 40.36% | 56.34% | 56.62% | 57.66% | 36.26% |
| Other Holding | 10.17% | 9.93% | 13.75% | 11.18% | 10.84% | 11.39% | 10.24% | 6.84% |
| Shareholder Count | 4,382 | 4,363 | 4,285 | 2,426 | 3,349 | 3,863 | 4,298 | 1,089 |
Gian Life Care Dividend Screener - Share Yield Analysis
Screen GIANLIFE dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Gian Life Care Index Membership - Market Screener Classification
Screen GIANLIFE by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Gian Life Care Market Events Screener - Corporate Actions
Screen GIANLIFE market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.18% | ||
| Annual General Meeting | NA | -4.49% | ||
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 0.72% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -9.72% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -1.58% |
| 2022-03-29 | 2022-03-30 | Bonus | 6:5 | 1.30% |
Gian Life Care Competitors Screener - Peer Comparison
Screen GIANLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 24,712 | 46.83 | 2,555 | 11.28% | 492 | 60.03 |
| Vijaya Diagnostic Centre | 10,935 | 70.34 | 700 | 23.06% | 144 | 57.20 |
| Metropolis Healthcare | 9,847 | 61.96 | 1,346 | 10.64% | 146 | 46.81 |
| Thyrocare Technologies | 7,366 | 56.28 | 702 | 20.80% | 91 | 48.33 |
| Nephrocare Health Services | 4,790 | 68.04 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,384 | 28.37 | 743 | 16.70% | 78 | 48.50 |
| Suraksha Diagnostic | 1,428 | 45.66 | 256 | 15.11% | 31 | 41.02 |
| One Global Service Provider | 1,243 | 28.65 | 148 | 134.60% | 19 | 59.79 |
| 3B BlackBio DX | 1,210 | 24.67 | 112 | 28.72% | 48 | 57.22 |
| Sastasundar Ventures | 996 | -103.51 | 1,171 | -18.47% | -134 | 38.32 |
Gian Life Care Company Announcements - News Screener
Screen GIANLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-10-18 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-06 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-10-04 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-10-04 | Proceedings Of AGM | View |
| 2025-09-10 | Reg. 34 (1) Annual Report. | View |
| 2025-09-10 | Shareholders Meeting On September 30 2025 | View |
| 2025-09-02 | Results For Quarter Ended June 30 2025 | View |
| 2025-09-02 | Results For Financial Year 01/04/2024-31/03/2025 | View |
| 2025-09-02 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday August 14 2025 | View |
| 2025-08-07 | Update on board meeting | View |
| 2025-08-07 | Board Meeting Intimation for Intimation Of Board Meeting To Consider And Approve Audited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Half Year And Year Ended 31St March 2025 | View |
| 2025-07-17 | Outcome Of Board Meeting Held On Friday February 14 2025 | View |
| 2025-07-17 | Board Meeting Outcome for Outcome Of Board Meeting Held On Friday February 14 2025 | View |
| 2025-02-10 | Board Meeting Intimation for Intimation Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Period Ended 31St December 2024 | View |
| 2024-11-14 | Outcome Of Board Meeting Held On Thursday, November 14, 2024 | View |
| 2024-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, November 14, 2024 | View |
| 2024-11-08 | Board Meeting Intimation for Intimation Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Half Year Ended 30Th September, 2024 | View |
| 2024-10-21 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | View |
| 2024-10-03 | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | View |
| 2024-10-01 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |